Literature DB >> 35379002

Comparison of the surgical resection and infarct 5/6 nephrectomy rat models of chronic kidney disease.

Ryan J Adam1,2, Adaysha C Williams1, Alison J Kriegel1,3,2,4.   

Abstract

The 5/6 nephrectomy rat remnant kidney model is commonly used to study chronic kidney disease (CKD). This model requires the removal of one whole kidney and two-thirds of the other kidney. The two most common ways of producing the remnant kidney are surgical resection of poles, known as the polectomy model, or ligation of superior and inferior segmental renal arteries, resulting in pole infarction. These models have much in common, but also major phenotypic differences, and thus respectively model unique aspects of human CKD. The purpose of this review is to summarize phenotypic similarities and differences between these two models and their relation to human CKD while emphasizing their vascular phenotype. In this article, we review studies that have evaluated arterial blood pressure, the renin-angiotensin-aldosterone-system, autoregulation, nitric oxide, single-nephron physiology, angiogenic and antiangiogenic factors, and capillary rarefaction in these two models. In terms of phenotypic similarities, both models spontaneously develop hallmarks of human CKD including uremia, fibrosis, capillary rarefaction, and progressive renal function decline. They both undergo whole organ hypertrophy, hyperfiltration of functional nephrons, reduced renal expression of vascular endothelial growth factor, increased renal expression of antiangiogenic thrombospondin-1, impaired renal autoregulation, and abnormal vascular nitric oxide physiology. In terms of key phenotypic differences, the infarction model develops rapid-onset, moderate to severe systemic hypertension and the polectomy model develops early normotension followed by mild to moderate hypertension. Rats subjected to the infarction model have a markedly more active renin-angiotensin-aldosterone system. Comparison of these two models facilitates understanding of how they can be used for studying CKD pathophysiology.

Entities:  

Keywords:  5/6 nephrectomy; autoregulation; blood pressure; chronic kidney disease; renin-angiotensin-aldosterone system

Mesh:

Substances:

Year:  2022        PMID: 35379002      PMCID: PMC9076416          DOI: 10.1152/ajprenal.00398.2021

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  196 in total

1.  Prescription of hormone replacement therapy in postmenopausal women with renal failure.

Authors:  C O Stehman-Breen; D Gillen; D Gipson
Journal:  Kidney Int       Date:  1999-12       Impact factor: 10.612

2.  Implication of peritubular capillary loss and altered expression of vascular endothelial growth factor in IgA nephropathy.

Authors:  Tamehachi Namikoshi; Minoru Satoh; Hideyuki Horike; Sohachi Fujimoto; Sayaka Arakawa; Tamaki Sasaki; Naoki Kashihara
Journal:  Nephron Physiol       Date:  2005-09-20

3.  Impaired autoregulation of GFR in hypertensive non-insulin dependent diabetic patients.

Authors:  P K Christensen; H P Hansen; H H Parving
Journal:  Kidney Int       Date:  1997-11       Impact factor: 10.612

4.  Effect of candesartan cilexetil (TCV-116) in rats with chronic renal failure.

Authors:  M Noda; T Matsuo; R Fukuda; M Ohta; H Nagano; Y Shibouta; T Naka; K Nishikawa; Y Imura
Journal:  Kidney Int       Date:  1999-09       Impact factor: 10.612

5.  Sustained expression of thrombospondin-1 is associated with the development of glomerular and tubulointerstitial fibrosis in the remnant kidney model.

Authors:  Christian Hugo; Duk-Hee Kang; Richard J Johnson
Journal:  Nephron       Date:  2002-04       Impact factor: 2.847

6.  Prevalence of chronic kidney disease in the United States.

Authors:  Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey
Journal:  JAMA       Date:  2007-11-07       Impact factor: 56.272

7.  Correlation of enhanced thrombospondin-1 expression, TGF-beta signalling and proteinuria in human type-2 diabetic nephropathy.

Authors:  Bernd Hohenstein; Christoph Daniel; Birgit Hausknecht; Kirsten Boehmer; Regine Riess; Kerstin U Amann; Christian P M Hugo
Journal:  Nephrol Dial Transplant       Date:  2008-07-30       Impact factor: 5.992

Review 8.  Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease.

Authors:  Yujiro Kida; Bie Nga Tchao; Ikuyo Yamaguchi
Journal:  Pediatr Nephrol       Date:  2013-03-10       Impact factor: 3.714

9.  Blood pressure lability and glomerulosclerosis after normotensive 5/6 renal mass reduction in the rat.

Authors:  Karen A Griffin; Maria M Picken; Anil K Bidani
Journal:  Kidney Int       Date:  2004-01       Impact factor: 10.612

Review 10.  Association of endothelial nitric oxide synthase Glu298Asp gene polymorphism with the risk of end-stage renal disease.

Authors:  Tian-Biao Zhou; Sheng-Sheng Yin
Journal:  Ren Fail       Date:  2013-03-07       Impact factor: 2.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.